Department of Cancer Control and Population Health, National Cancer Center Graduate School of Cancer Science and Policy, 323 Ilsan-ro, Ilsandong-gu, Goyang-si 410-769, Korea.
National Cancer Control Institute, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu, Goyang-si 410-769, Korea.
Int J Environ Res Public Health. 2020 Oct 19;17(20):7592. doi: 10.3390/ijerph17207592.
Infection is a major cause of cancers. We estimated the economic burden of cancers attributable to infection in 2014 in Korea, where cancer causing infection is prevalent, but the economic burden of it has never been examined. Cancer patients were defined as those having made medical claims as recorded by the National Health Insurance Service, which is a mandatory insurance for all citizen. We multiplied the costs by the population-attributable fraction for each type of cancer. The study included direct and indirect costs, where direct costs comprised direct medical and non-medical costs of inpatients and outpatients, while indirect costs were estimated by identifying future income loss due to premature death, productivity loss during hospitalization/outpatient visits, and job loss. In 2014, there were 100,054 infection-related cancer patients, accounting for 10.7% of all Korean cancer cases for that year. Direct costs of cancers associated with infection stood at nearly USD 676.9 million, while indirect costs were much higher at USD 2.57 billion. The average expenditure of a typical patient was USD 32,435. Economic burden of cancers attributable to infection is substantial in Korea, accounting for 0.23% of the national gross domestic product and 1.36% of national healthcare expenditure in 2014.
感染是癌症的主要病因之一。我们估算了 2014 年韩国因感染导致的癌症的经济负担，因为该国存在导致癌症的感染，但从未对此进行过经济负担的研究。癌症患者是指国家健康保险服务记录的有医疗索赔的患者，国家健康保险服务对所有公民都是强制性保险。我们将每种癌症的人群归因分数乘以成本。研究包括直接和间接成本，直接成本包括住院和门诊患者的直接医疗和非医疗成本，而间接成本是通过确定因过早死亡而导致的未来收入损失、住院/门诊期间的生产力损失以及失业来估算的。2014 年，有 100054 例与感染相关的癌症患者，占当年韩国所有癌症病例的 10.7%。与感染相关的癌症的直接成本约为 6.769 亿美元，而间接成本则高得多，为 25.7 亿美元。典型患者的平均支出为 32435 美元。韩国因感染导致的癌症的经济负担很大，占 2014 年国内生产总值的 0.23%，占国家医疗保健支出的 1.36%。
